M&A Deal Summary

GSK Acquires Elsie Biotechnologies

On June 6, 2024, GSK acquired life science company Elsie Biotechnologies for 50M USD

Acquisition Highlights
  • This is GSK’s 26th transaction in the Life Science sector.
  • This is GSK’s 28th largest (disclosed) transaction.
  • This is GSK’s 19th transaction in the United States.
  • This is GSK’s 6th transaction in California.

M&A Deal Summary
Date 2024-06-06
Target Elsie Biotechnologies
Sector Life Science
Buyer(s) GSK
Deal Type Add-on Acquisition
Deal Value 50M USD

Target

Elsie Biotechnologies

San Diego, California, United States
Elsie is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics by integrating discovery, development, and delivery to potentially increase potency, decrease toxicity, and optimise delivery. Elsie Biotechnologies is based in San Diego, California

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GSK

Brentford, United Kingdom
Category Company
Founded 1715
Sector Life Science
Employees70,212
Revenue 30.3B GBP (2023)
DESCRIPTION
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.

GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.

DEAL STATS #
Overall 32 of 32
Sector (Life Science) 26 of 26
Type (Add-on Acquisition) 24 of 24
State (California) 6 of 6
Country (United States) 19 of 19
Year (2024) 2 of 2
Size (of disclosed) 28 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-09 Aiolos Bio

San Francisco, California, United States

Aiolos Bio is a clinical-stage, private, biopharmaceutical company dedicated to revolutionising the treatment landscape for respiratory disease. Aiolos Bio is based in San Francisco, California.

Buy $1.4B
Mergr

Product

Company

Legal